Category Archives: Alternative Cancer Treatment

Innovative Research Aims to Snatch Cancer Cells by Magnetism and Nanoparticles

Innovative Research Aims to Snatch Cancer Cells by Magnetism and Nanoparticles
Innovative Research Aims to Snatch Cancer Cells by Magnetism and Nanoparticles

The more precise diagnostic methods are, the more effective immunotherapy for cancer can be. In a case of “opposites attract,” scientists recently took a giant step toward improved diagnostics with the principles of magnetism.

Putting a “Charge” in Cancer Cells

Liquid biopsy is a cancer screening technique in which blood is drawn from a patient and tested for circulating tumor cells, or CTCs. Unfortunately, CTCs are so few and far between that the blood sample may be completely free of them, resulting in a false diagnosis.

In a study published in Nature Biomedical Engineering, a team of researchers at Stanford University School of Medicine tested a group of pigs with CTCs in their bloodstream.

– The CTCs were first tagged with a nanoparticle containing magnetic properties.

– In the next step, a small wire was inserted near the pig’s ear in a vein that is comparable to the ones in a human arm.

– As the tagged tumor cells drifted by, the magnetic pull caused them to stick to the wire, which was then removed from the vein.

What’s Next?

Not only did the magnetic method detect 10 to 80 times more CTCs than a typical liquid biopsy, it found 500 to 5,000 more tumor cells than an earlier wire-based model. Dr. Sanjiv Sam Gambhir of Stanford expressed hope that the wire device could have applications for cancer treatment as well as diagnosis.

Thorough and Non-Invasive Diagnostic Procedures at Issels®

Our extensive diagnostic procedures let us create a personalized immunotherapy for cancer program that incorporates a number of complementary methods to treat the tumor along with its environment. Contact us for more information.

Gas Embolotherapy Combined with Ultrasound May Block Cancer Tumor’s Blood Supply

New Cancer Treatments Are Being Studied Worldwide
New Cancer Treatments Are Being Studied Worldwide

Scientists are constantly searching for methods of cancer treatment that will kill tumor cells without affecting healthy tissue, thereby avoiding common side effects. A research team recently found that bubbles may be a surprising vehicle for starving tumors and delivering anti-cancer drugs.

“Starving” Cancer Cells

Tumor cells rely on a steady blood supply to furnish oxygen and nutrients required to multiply and spread to other parts of the body. In its absence, tumors use a process called angiogenesis to create new blood vessels.

Scientists had previously created a class of drugs known as angiogenesis inhibitors, which effectively halt blood vessel development. Embolization is an alternate method that incorporates drugs or nano-sized beads to block blood vessels.

A Non-Surgical Option to Defeat Cancer?

Gas embolization is a variation in which bubbles are used to create a blockage. Prof. Yi Feng and a team of scientists at Xi’an Jiaotong University in China conducted a study using blood vessel-rich intestinal tissue from rats.

In the first step, droplets of dodecafluoropentane, a fluorocarbon often used for conversion to gas microbubbles, were injected into the blood vessels. An ultrasound was then applied in a technique known as acoustic droplet vaporization (ADV).

As a result, the droplets formed bubbles that congregated in an area, with some of them uniting to create larger bubbles, effectively blocking the blood vessels. The team is hopeful that gas embolotherapy may eventually be used as a “double punch” attack on cancer.

Immunotherapy: Individually Created Cancer Treatment

For years, Issels® has helped patients with our non-toxic cancer treatment programs that boost the body’s own immune system. Visit our website for more information.

Personalized Immunotherapy: The Future for Cancer Treatment One Story

Immunotherapy is Changing Cancer Treatment Again in Exciting New Ways
Immunotherapy is Changing Cancer Treatment Again in Exciting New Ways

At Issels®, we recognize that successful cancer treatment is designed for a patient’s individual needs. This immunotherapy approach recently saved the life of one woman whose recurring breast cancer was spreading to other parts of her body.

“Two to Three Months to Live”

In 2003, Judy Perkins of Port St. Lucie, Florida underwent a mastectomy after being diagnosed with breast cancer. Just over two years ago the cancer returned, resulting in tennis-ball-sized tumors throughout her torso, including the lymph nodes.

This time around, Perkins was treated by Dr. Steven Rosenberg and his team at the National Cancer Institute. Rosenberg’s career has been devoted to the field of immuno-oncology, which involves finding ways to help the body’s own immune system attack and destroy cancer cells.

Weaponizing the Immune System

Rosenberg and his team began by obtaining samples of the tumors to sequence DNA and analyze tumor-fighting immune cells called lymphocytes. The scientists were then able to identify the specific gene mutations that allowed cancer cells to multiply and spread.

After determining which lymphocytes were most effective against the mutations, the team grew those cells in the lab and re-introduced them to Perkins’ system. In addition to doses of interleukin 2 and an immunotherapy drug approved by the FDA in 2017, Perkins received one last round of chemotherapy.

All tumors disappeared, and Perkins remains cancer-free today. Rosenberg is optimistic that this success will propel immunotherapy research to more breakthroughs.

Personalized, Integrative Cancer Treatment at Issels®

Many patients with advanced and therapy-resistant cancers have achieved long-term remission through our cancer treatment programs. Contact us to learn more.

Genetic Testing Identifies Best Immunotherapy Prospects for Prostate Cancer Patients

New Treatments for Prostate Cancer
New Treatments for Prostate Cancer

While immunotherapy has proven to be a viable form of cancer treatment, not all patients respond to the currently available methods. A major breakthrough occurred this summer, when scientists found that genetic testing could identify prostate cancer patients who are likely candidates for immunotherapy.

Treating Prostate Cancer with Immunotherapy

Last June, a major clinical trial provided the first evidence that advanced prostate cancer could be successfully treated with an immunotherapy drug called pembrolizumab. Approximately ten percent of patients responded, so the question became how to determine which patients to treat.

A possible answer came in the form of a study recently published in Cell. Scientists from London’s Institute of Cancer Research and the University of Michigan joined forces to analyze tumor DNA collected from 360 men with advanced prostate cancer in various countries.

Is Genetic Testing the Solution?

Results indicated that seven percent of the tumors lacked a gene called CDK12. This feature is a hallmark of a unique genetic pattern that contains a greater amount of immune cells than other types of advanced prostate cancer.

In addition, these tumors had more neoantigens, which are proteins that alert the immune system to the presence of cancer cells. Thanks to the higher numbers of immune cells and neoantigens, the immune system already begins to recognize the tumor, which is why scientists think such tumors are more receptive to immunotherapy.

Cancer Treatment for Therapy-Resistant Tumors

Issels® uses genetic testing to individually develop cancer treatment programs that are best suited to a patient’s specific needs. Visit our website to learn how we have been successfully using integrative immunotherapy methods to treat advanced cancer.

Lung Cancer Numbers Rise in Female Non-Smoking Populations

Cancer Rising in Female Non-Smokers
Cancer is Rising in Female Non-Smokers

As the most common form of the disease worldwide, lung cancer is a primary target of immunotherapy for cancer research and testing. Unfortunately, scientists are alarmed at the rising incidence of lung cancer in women and non-smokers.

Non-Smokers Are Not Immune to Lung Cancer

The link between tobacco and lung cancer is well-known, leaving many people to mistakenly believe that only smokers will develop the disease. The facts are that approximately 15 percent of lung cancer cases are non-tobacco-related.

This anomaly is especially pronounced among women. Studies show that 20 percent of women who are diagnosed with lung cancer are lifelong non-smokers, compared to only 10 percent of men. Data from the U.K. reveals that, among patients undergoing lung cancer surgery over a six-year period, women made up 67 percent of the group that had never smoked.

Lung Cancer and the Gender Gap

In another dubious distinction, lung cancer rates in women have risen over the last 20 years, even as they’ve fallen in men. Researchers attribute this development to two possible causes:

– There is some evidence that women’s DNA is more vulnerable to damage caused by carcinogens contained in tobacco.

– At one time, smoking among women was relatively rare. Gains in gender equality appear to have resulted in more women taking up the habit.

Scientists urge anyone who experiences symptoms such as unexplained coughing, chest pains and shortness of breath to see their doctor, even if they’ve never smoked.

Immunotherapy for Cancer: When Other Treatments Have Failed

Our personalized immunotherapy for cancer programs have helped patients with both primary lung cancer and lung metastases. Contact us for more information.

Test on New Drug that Contains Cancer Cell Metastasis

Tests on New Drugs That May Provide Better Treatment
Tests on a New Drug That May Contain the Spread of Cancer

At Issels®, our immunotherapy for cancer treatments are often used with patients whose tumors have spread to other parts of the body. Over the last few years, an international research team has made significant progress in developing a drug that limits the movement of cancer cells.

Stopping the Spread of Cancer Cells

Metastasis is the term for the ability of cancer cells to move throughout the body and establish tumors in locations away from the primary site. Once a tumor metastasizes, it presents a greater challenge for successful treatment.

While cancer research primarily focuses on treating tumors directly, a multinational team of scientists decided to investigate possible methods of interfering with cancer cells’ motility. If migration could be contained, it would help prevent tumors from entering later, hard-to-treat stages.

KBU2046: Putting the Brakes on Metastasis

In 2011, the team identified a drug called KBU2046 that binds to heat-shock proteins found in all cells, preventing cell movement. Original testing was done on human cell models of breast, prostate, lung and colon cancer in vitro.

The team’s most recent study, published in June, extended testing to mouse models. Scientists were able to confirm that KBU2046 targeted cancer cells only, sparing healthy tissue, and further refinements eliminated any side effects.

The researchers believe that the positive results justify their unorthodox approach. Next step on their agenda is obtaining funds to conduct further studies in preparation for clinical trials.

Integrative Immunotherapy Treatments for Late-Stage Cancer

Numerous patients with advanced and therapy-resistant tumors have achieved long-term remission with our personally developed immunotherapy for cancer programs. Visit our website to hear and read their first-person testimonials.